Live Breaking News & Updates on Cytokine Production

Stay updated with breaking news from Cytokine production. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

[Full text] Design, Synthesis, Molecular Modelling, and Biological Evaluation of O

1Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Srinagar, India;
2Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER), Sahibzada Ajit Singh Nagar, India;
3Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia;
4Department of Molecular Science and Technology, Ajou University, Suwon, South Korea
Correspondence: Mubashir Hussain Masoodi
Tel +919419076525
Email [email protected]
Introduction: Oleanolic acid, a pentacyclic triterpenic acid, is widely distributed in medicinal plants and is the most commonly studied triterpene for various biological activities, including anti-allergic, anti-cancer, and anti-inflammatory.
Methods: The present study was carried out to synthesize arylidene derivatives of oleanolic acid at the C-2 position by Claisen Schmidt condensation to develop more effective ....

United States , United Kingdom , Claisen Schmidt , From Gibco United States , San Diego , From Qualigens , Arylidene Oleanolic Acid , Acid Arylidene Derivatives Varying , Aromatic Ring , Oic Acid , Cell Viability , Cytokine Production , Predicted Interaction , Pro Inflammatory Cytokines , Cyscore Score Along , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , இருந்து கிப்கோ ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , நறுமணமுள்ள மோதிரம் , ஒய்க் அமிலம் , செல் நம்பகத்தன்மை ,

Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases

Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases
Corbus Pharmaceuticals Holdings, Inc.
Norwood, Massachusetts, UNITED STATES
Presentations about compounds in Corbus’ pipeline will highlight mechanistic studies of lenabasum, a CB2 agonist, and preclinical data from CB2 agonist oncology program and CB1 inverse agonist metabolism program
Norwood, MA, Jan. 20, 2021 (GLOBE NEWSWIRE) Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced it will participate in the New York Academy of Sciences’
webinar on January 27, 2021 on the endocannabinoid system as a target for therapeutic agents. ....

New York , United States , New York Academy Of Sciences , Lindsey Smith , Derek Gilroy , Ping Zhang , Ted Jenkins , Barbara White , University College London , Head Of Research , Corbus Pharmaceuticals Holdings Inc , Exchange Commission , Corbus Pharmaceuticals Contacts , York Academy Of Science , Academy Of Sciences , Corporate Communications , Securities Exchange , York Academy Of Sciences , Pharmaceuticals Holdings , New York Academy , New Insights , Acute Inflammation , Humans Provided , Synthetic Analogue , University College , Therapeutic Potential ,